<--- Back to Details
First PageDocument Content
Morphinans / Euphoriants / Alcohols / Ketones / Ethers / Opioid use disorder / Opioid / Methadone / Naltrexone / Buprenorphine / Substance dependence
Date: 2015-06-02 23:20:01
Morphinans
Euphoriants
Alcohols
Ketones
Ethers
Opioid use disorder
Opioid
Methadone
Naltrexone
Buprenorphine
Substance dependence

Determining the impact of opioid substitution therapy upon mortality and recidivism among prisoners: A 22 year data linkage study Natasa Gisev, Sarah Larney, Jo Kimber, Lucy Burns, Don Weatherburn, AmyGibson, Tim Dobbins

Add to Reading List

Source URL: www.criminologyresearchcouncil.gov.au

Download Document from Source Website

File Size: 630,59 KB

Share Document on Facebook

Similar Documents

Microsoft Word - VLD Packet.FINAL

Microsoft Word - VLD Packet.FINAL

DocID: 1rubZ - View Document

Atlantic Pharmaceuticals Announces Successful Pre-IND Meeting with the FDA on Immediate Release, Abuse-Deterrent Hydrocodone Atlanta, GA., August 13, 2013. Atlantic Pharmaceuticals, Inc., a specialty pharmaceutical compa

Atlantic Pharmaceuticals Announces Successful Pre-IND Meeting with the FDA on Immediate Release, Abuse-Deterrent Hydrocodone Atlanta, GA., August 13, 2013. Atlantic Pharmaceuticals, Inc., a specialty pharmaceutical compa

DocID: 1rtjz - View Document

TITAN	PHARMACEUTICALS	  CORPORATE	PRESENTATION	Ÿ	SUNIL	BHONSLE	Ÿ	JUNE	2016 ©	2016	TITAN	PHARMACEUTICALS	INC.	Ÿ	NASDAQ:TTNP

TITAN PHARMACEUTICALS CORPORATE PRESENTATION Ÿ SUNIL BHONSLE Ÿ JUNE 2016 © 2016 TITAN PHARMACEUTICALS INC. Ÿ NASDAQ:TTNP

DocID: 1rsmr - View Document

Sunil Bhonsle  Mar 2015 Corporate Presentation

Sunil Bhonsle Mar 2015 Corporate Presentation

DocID: 1rrwl - View Document

Adapt v13_doc revised

Adapt v13_doc revised

DocID: 1rrqr - View Document